palmitoleic acid

Small moleculeexperimental

Palmitoleic acid, or (9Z)-hexadec-9-enoic acid, is an omega-7 monounsaturated fatty acid (16:1n-7) with the formula CH3(CH2)5CH=CH(CH2)7COOH. It is a rare component of fats. It is a common constituent of the glycerides of human adipose tissue. It is present in all tissues but, in general, found in higher concentrations in the liver. — Wikipedia

Clinical trial activity

5 trials · 5 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Jan 1, 2013 (NCT01771224)

Timeline

2010s

  1. Jan 1, 2013

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2018

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetAntioxidant

    Antioxidant

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 9-cis-hexadecenoic acid
  • 9-cis-hexadecenoic acid
  • 9-hexadecenoic acid
  • (9z)-hexadecenoic acid
  • (9z)-hexadecenoic acid
  • c16:1n7
  • c16:1 trans-9
  • cis-9-hexadecenoic acid
  • cis-9-hexadecenoic acid
  • palmitelaidic acid
  • palmitoleate
  • palmitoleate
  • palmitoleic acid
  • palmitoleic acid
  • palmitoleic acid
  • palmitoleic acid
  • palmitoleic acid, (e)-isomer
  • palmitoleic acid, potassium salt, (z)-isomer
  • palmitoleic acid, sodium salt, (z)-isomer
  • palmitoleic acid, (z)-isomer
  • palmitolinoleic acid
  • palmitolinoleic acid
  • (z)-9-hexadecenoic acid
  • (z)-9-hexadecenoic acid
  • (z)-hexadec-9-enoic acid
  • (z)-hexadec-9-enoic acid
  • zoomaric acid
  • zoomaric acid

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05560971N/ANov 1, 2022Harvard University
NCT03625427N/ANov 30, 2018University of North Carolina at Chapel Hill
NCT03372733Phase 2Jul 31, 2018National Heart, Lung, and Blood Institute (NHLBI)
NCT02311790N/AJul 1, 2015Tufts University
NCT01771224Early Phase 1 (Phase 1)Jan 1, 2013Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (5)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Harvard UniversityAcademic/Hospital1112022
Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranGovernment1112013
National Heart, Lung, and Blood Institute (NHLBI)Government1112018
Tufts UniversityAcademic/Hospital1112015
University of North Carolina at Chapel HillAcademic/Hospital1112018
5 organizations
Page 1 / 1